About MIRA Pharmaceuticals
MIRA Pharmaceuticals is a company based in Baltimore (United States) founded in 2020.. The company has 5 employees as of December 31, 2024. MIRA Pharmaceuticals has completed 1 acquisition, including SKNY Pharmaceuticals. MIRA Pharmaceuticals offers products and services including Ketamir and MIRA-55. MIRA Pharmaceuticals operates in a competitive market with competitors including GW Pharma, IGC Pharma, NEUROPATHIX, Agrithera and Lyfe Organics, among others.
- Headquarter Baltimore, United States
- Employees 5 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mira Pharmaceuticals, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-7.85 M34.46as on Dec 31, 2024
-
EBITDA
$-8.02 M5.95as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
5
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MIRA Pharmaceuticals
MIRA Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol MIRA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of MIRA Pharmaceuticals
MIRA Pharmaceuticals offers a comprehensive portfolio of products and services, including Ketamir and MIRA-55. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Oral ketamine analog for treating neurologic and neuropsychiatric disorders.
Pharmaceutical marijuana analog targeting pain relief and therapeutic markets.
Unlock access to complete
Unlock access to complete
Funding Insights of MIRA Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by MIRA Pharmaceuticals
MIRA Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SKNY Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for weight loss and smoking cessation are developed.
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - MIRA Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mira Pharmaceuticals Comparisons
Competitors of MIRA Pharmaceuticals
MIRA Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GW Pharma, IGC Pharma, NEUROPATHIX, Agrithera and Lyfe Organics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cannabinoid medicines for MS spasticity, cancer pain and childhood epilepsy
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products targeting neurological disorders like Alzheimer's are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics targeting inflammation, neurodegeneration, oxidative stress, and neuropathic pain
|
|
| domain | founded_year | HQ Location |
Cannabis-based therapeutics are developed for pain and neurological disorders.
|
|
| domain | founded_year | HQ Location |
Cannabinoid tinctures and isolates are produced from Cannabis Sativa.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mira Pharmaceuticals
Frequently Asked Questions about MIRA Pharmaceuticals
When was MIRA Pharmaceuticals founded?
MIRA Pharmaceuticals was founded in 2020.
Where is MIRA Pharmaceuticals located?
MIRA Pharmaceuticals is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Who is the current CEO of MIRA Pharmaceuticals?
Erez Aminov is the current CEO of MIRA Pharmaceuticals.
How many employees does MIRA Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at MIRA Pharmaceuticals is 5.
What does MIRA Pharmaceuticals do?
Therapeutics based on cannabinoids are developed by MIRA Pharmaceuticals, founded in 2020 and located in Baltimore, United States. Focus is placed on targeting CB1 and CB2 receptors to address conditions such as phobias, social anxiety disorder, PTSD, generalized anxiety disorder, panic disorder, and chronic pain. Operations center on pharmaceutical development within the biotech sector, with an emphasis on innovative treatments for mental health and pain management.
Who are the top competitors of MIRA Pharmaceuticals?
MIRA Pharmaceuticals's top competitors include IGC Pharma, GW Pharma and NEUROPATHIX.
What products or services does MIRA Pharmaceuticals offer?
MIRA Pharmaceuticals offers Ketamir and MIRA-55.
Is MIRA Pharmaceuticals publicly traded?
Yes, MIRA Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol MIRA.
How many acquisitions has MIRA Pharmaceuticals made?
MIRA Pharmaceuticals has made 1 acquisition, including SKNY Pharmaceuticals.
What is MIRA Pharmaceuticals's ticker symbol?
The ticker symbol of MIRA Pharmaceuticals is MIRA on NASDAQ.